Table 3.

Analysis of relationship between adverse drug reaction (ADR) and first acute hospitalization, implicated drug-drug interactions, and avoidability of such events in all patients with rheumatoid arthritis (RA).

ADR-related admissionsDefiniteProbablePossibleUnlikely
N (%)4 (2.3)8 (4.6)77 (44.5)84 (48.6)
RA drug implicated, n (%)
  Definitely2 (50.0)4 (50.0)40 (51.9)NA
  Corticosteroid implicated, n (%)
    Definitely0 (0.0)0 (0.0)8 (20.0)
    Unlikely2 (100.0)3 (75.0)26 (45.0)
  DMARD implicated, n (%)
    Definitely2 (100.0)3 (75.0)27 (67.5)
    Unlikely0 (0.0)1 (25.0)9 (22.5)
  Biologic implicated, n (%)
    Definitely0 (0.0)3 (75.0)9 (22.5)
    Unlikely2 (100.0)1 (25.0)29 (72.5)
  Unlikely2 (50.0)4 (50.0)33 (42.9)NA
Drug-drug interaction implicated, n (%)
  No1 (25.0)0 (0.0)15 (19.5)NA
  Moderate1 (25.0)5 (62.5)57 (74.0)NA
  Major2 (50.0)3 (37.5)5 (6.5)NA
Avoidability, n (%)
  Definitely2 (50.0)1 (12.5)1 (1.3)NA
  Possibly1 (25.0)6 (75.0)54 (70.1)NA
  Unavoidable1 (25.0)1 (12.5)22 (28.6)NA
  • DMARD: disease-modifying antirheumatic drug; NA: not applicable.